What are the current FDA warnings and telehealth availability rules for online weight loss medication prescriptions?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the current FDA warnings and telehealth availability rules for online weight loss medication prescriptions?
4 real searches · 1 real-search pass
FDA current warnings compounded semaglutide tirzepatide telehealth online weight loss prescriptions October 2026 FDAGoogle ↗
OBSERVED
FDA telehealth online pharmacy GLP-1 weight loss medication warning compounded drugs 2026Google ↗
OBSERVED
FDA drug shortage semaglutide tirzepatide compounding enforcement policy 2026Google ↗
OBSERVED
DEA telemedicine prescribing weight loss medications non controlled state medical licensing telehealth 2026 rulesGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
FDA current warnings compounded semaglutide tirzepatide telehealth online weight loss prescriptions October 2026 FDA Google ↗
FDA telehealth online pharmacy GLP-1 weight loss medication warning compounded drugs 2026 Google ↗
FDA drug shortage semaglutide tirzepatide compounding enforcement policy 2026 Google ↗
DEA telemedicine prescribing weight loss medications non controlled state medical licensing telehealth 2026 rules Google ↗
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize · fda.gov
- FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List · fda.gov
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · fda.gov
- Internet Pharmacy Warning Letters · fda.gov
- FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s · fda.gov
- FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs · fda.gov
- DailyMed - ZEPBOUND- tirzepatide injection, solution ZEPBOUND- tirzepatide injection, solution ZEPBOUND KWIKPEN- tirzepatide injection, solution · dailymed-us-east-1.awsprod.nlm.nih.gov
- FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications · fda.gov
- Licensing across state lines · telehealth.hhs.gov
- Getting started with licensure · telehealth.hhs.gov
- Prescribing controlled substances via telehealth · telehealth.hhs.gov
- HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026 · hhs.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
FDA current warnings compounded semaglutide tirzepatide telehealth online weight loss prescriptions October 2026 FDA OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA telehealth online pharmacy GLP-1 weight loss medication warning compounded drugs 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA drug shortage semaglutide tirzepatide compounding enforcement policy 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
DEA telemedicine prescribing weight loss medications non controlled state medical licensing telehealth 2026 rules OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |